Method of treating thrombocytopenia using human BCDF in combinat

Details Method of treating thrombocytopenia using human BCDF in combinat Method of treating thrombocytopenia using human BCDF in combinat

1992-01-09

1994-05-10

Hill, Jr., Robert J.

Drug, bio-affecting and body treating compositions

Lymphokine

Interleukin

424 856, 530351, 514 12, A61K 3766, A61K 3702

Patent

active

053105508

ABSTRACT:
Thrombocytopenia is treated by administering a subject suffering from thrombocytopenia a composition containing human B cell differentiation activity in combination with IL-3.

REFERENCES:
Koike et al. J. Exp. Med. 168:879-890 (1988).
Bergui et al. J. Exp. Med. 170:613-618 (1989).
Ishibashi et al. Blood 74(4): 1241-1244 (1989).
Hirano et al Nature 324: 73-76 (1986).
May et al. Proc. Natl. Acad. Sci. 83: 8957-8961 (1986).
Yasukawa et al EMBOJ 6: 2939-2945 (1987).
Van Damme et al. J. Immunol 140: 1534-1541 (1988).

Affiliated with

Also associated with

Rating

Method of treating thrombocytopenia using human BCDF in combinat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating thrombocytopenia using human BCDF in combinat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating thrombocytopenia using human BCDF in combinat will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2411553